Your session is about to expire
← Back to Search
Multimodal Teleprehabilitation for Abdominal Cancer
Study Summary
This trial aims to deliver a prehabilitation program to all cancer patients scheduled for surgery at the MUHC, addressing the patients' risk factors in patients' pandemic reality perspective.
- Abdominal Cancer
- Lung Cancer
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the principal intent of this experiment?
"This clinical trial, lasting a period of 1.5 years and evaluated through study completion, hopes to evaluate primary outcomes such as drop-outs for rational analysis. Secondary objectives encompass the WHO Disability Assessment Schedule v2.0 (WHODAS) to measure disability free survival at specific intervals, Body Mass Index (BMI), ranging from 18 - 30 with anything above 30 considered obesity and below 18 malnourished, and The 30-day Mortality which counts the number of deaths within a month post-surgery."
Is it possible to enrol in this investigation at the present time?
"Affirmative. The clinical trial's listing on clinicaltrials.gov confirms that recruitment is in progress; it was originally posted on March 12th 2021 and the last update occurred September 24th 2021. A total of 100 individuals are being sought to join this research at one particular site."
How many participants are currently engaged in this clinical experiment?
"Affirmative. Data on clinicaltrials.gov suggests that this medical research, which was initially uploaded on March 12th 2021 is actively recruiting patients to participate in the study. Approximately 100 individuals are needed at 1 different sites for completion of the trial."
Share this study with friends
Copy Link
Messenger